Tag Archives: bioavailability
A new strategy to deliver anti-cancer nanodrugs and decrease their toxic side effects by temporarily blunting the RES uptake using Intralipid®
Nanodrugs, or nanotechnology-based therapeutics, show great promise for treating a number of diseases, including cancer. However, an analysis of the literature from the past 10 years finds that in studies of cancer nanodrugs, a very small fraction
Providing the evidence necessary to make informed decisions for contaminated land
The last 40 years of ‘environmental revolution’ in Europe and beyond has helped to establish comprehensive frameworks built around preventing pollution and risk-based management. After various lessons learnt, several countries, namely the United Kingdom, Netherlands, Belgium, the
Promises and challenges in the engineering of nanosized active pharmaceutical ingredients
The advances in the field of nanotechnology have revolutionized the field of delivery of poorly soluble active pharmaceutical ingredients (APIs). Nanoparticles refer to solid colloidal three-dimensional particles in the size range from (1 to 1000) nm. Therapeutically,
Adding phospholipid to drug formulation: a promising approach to improve drug absorption
For a patient to benefit from the therapeutic effects of any medicine, the prerequisite is that the drug is adequately absorbed after drug intake. Unfortunately, at least 40% of the marketed drugs and up to 90% of
